BioPharma Clinical Trials
Sirnaomics' STP707 Shows Promise in Phase I Solid Tumor Study
Six cohorts, totaling 50 late-stage cancer patients, received STP707 four times monthly by intravenous infusion at escalating dosages. All cohorts demon...
September 01, 2023 | News
HiRO Boosts G lobal Presence and Operations with Courante Oncology Acquisition
As a reputable boutique CRO with a strong track record of delivering high-quality, expedited clinical trials in the Asia-Pacific, HiRO's acquisit...
September 01, 2023 | News
Elevating Energy Efficiency and Sustainability in the Pharmaceutical Industry
Explore an in-depth conversation with Jackson Seng as he sheds light on the successful partnership between Schneider Electric and Takeda, leading to the es...
August 31, 2023 | News
South Korea's Genexine's Long-Acting Growth Hormone Meets Phase 3 Endpoint
Phase 3 clinical trial in China meets primary endpoint On track to file BLA in China in 2024 The study being conducted by Genexine’s partner in...
August 31, 2023 | News
HUTCHMED Receives Breakthrough Therapy Designation in China for Savolitinib for Gastric Cancer
The study of savolitinib is a single-arm, multi-center, open-label, Phase II registration study to evaluate the efficacy, safety and tolerability of savoli...
August 29, 2023 | News
Zhiyi Biotech Begins Phase 1 Trial of SK10 for Chemo-induced Diarrhea
SK10, the first Bacteroides fragilis-based live biotherapeutic product (LBP) obtained FDA IND approval, is also the first LBP of Next-generation probi...
August 28, 2023 | News
Agenus Focuses on Fast-Tracking BOT/BAL Program for Cancer
Agenus Inc. (“Agenus”) (Nasdaq: AGEN), a pioneer in immuno-oncology, today announced a strategic initiative to prioritize and focus resources t...
August 24, 2023 | News
SK Bioscience and Vaxxas Partner for Needle-Free Typhoid Vaccine Patch
SK bioscience and Vaxxas have officially entered into a Joint Development Agreement. This collaboration is set to revolutionize vaccine delivery by devel...
August 24, 2023 | News
Lynk Pharma's LNK01001 Shows Positive Results in Ankylosing Spondylitis Phase II Trial
The study, led by Professor Xiaofeng Zeng, the director of the Department of Rheumatology and Immunology of Peking Union Medical College Hospital and ...
August 23, 2023 | News
MGI Partners with NGeneBio to Advance Precision Medicine
This strategic partnership will enable the integration of NGeneBio's advanced diagnostic assays with MGI's high-throughput sequencing technology to acceler...
August 23, 2023 | News
CanariaBio's MAb-AR20.5 for Pancreatic Cancer Granted FDA Orphan Drug Designation
CanariaBio Inc., a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative immunotherapies for cancer, anno...
August 22, 2023 | News
3Z and biotx.ai Forge Partnership to Advance ADHD Drug Development Using AI Modelling
3Z, holds expertise in developing genetically engineered models of central nervous system disorders, has successfully identified potential ADHD treatments ...
August 19, 2023 | News
Neurophth Begins Phase I/II Trial for Second Gene Therapy with First Patient Dosed
Neurophth is conducting a Phase I/II, multi-region, multi-center, single-arm, open-labeled, dose-finding study aimed at evaluating the safety, tole...
August 18, 2023 | News
Minghui Pharma Enrolls First Patient in Phase 3 Study for MH004 Cream in Atopic Dermatitis
The phase 3 clinical trial aims to evaluate the safety and efficacy of the investigational topical cream in a larger patient population. Leveraging the con...
August 18, 2023 | News
Most Read
- Lack of Regular Screening Fuels Rise in Late-Stage Breast Cancer in Hong Kong, New Report Reveals
- BIOCHINA 2025: Connecting Global Innovators with China's Leading Biotech Firms
- Leon Wyszkowski, President of Analytical Services, Discusses Thermo Fisher's Strategic Move: Expanding Bioanalytical Capabilities in Europe with New Sweden Lab
- The Role of Policy and Public Health Initiatives in Addressing Women's Cancer Care in Asia
- Redefining Patient Safety in the Age of Healthtech
Bio Jobs
- Avance Clinical Appoints Jessica Han as Director of Asian Operations, Strengthening Commitment to the Asian Market
- Bristol Myers Squibb Employees Cycle Coast-to-Coast to Raise $1 Million for Cancer Research
- Pfizer Australia Commits $150M to Upgrade Melbourne Facility, Bolstering Global Fight Against Antimicrobial Resistance
- SMi Systems Appoints Dr. Stefan Hamill as Vice President of Strategy to Drive Commercialisation and Growth
- Thermo Fisher Scientific Appoints William Hung as Senior Director and General Manager for Taiwan
- Cytiva Appoints Industry Veteran Pierre-Alain Ruffieux as Chief Operating Officer
News
Editor Picks
